Eicos Sciences is dedicated to advancing and bringing to market transformative prostacyclin therapies that can significantly enhance patient outcomes in medical conditions where treatment options are scarce or nonexistent. Our emphasis on Prostacyclin analogs stems from research indicating PGI2's efficacy as a potent vasodilator with antiplatelet, antiproliferative, and anti-inflammatory properties. Our therapeutic pipeline is...
Eicos Sciences is dedicated to advancing and bringing to market transformative prostacyclin therapies that can significantly enhance patient outcomes in medical conditions where treatment options are scarce or nonexistent. Our emphasis on Prostacyclin analogs stems from research indicating PGI2's efficacy as a potent vasodilator with antiplatelet, antiproliferative, and anti-inflammatory properties. Our therapeutic pipeline is currently concentrated on addressing various challenging conditions, including frostbite, systemic sclerosis, and ECMO, to provide effective solutions where limited treatment options currently exist.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.